Nasdaq Stockholm AB: New equity right for trading, Pharmacolog i Uppsala TO3 B (416/23)

At the request of Pharmacolog i Uppsala AB (publ) equity rights will be traded
on First North as from 

August 7, 2023.



Security name: Pharmacolog i Uppsala TO3 B
-------------------------------------------
Short name:   PHLOG TO3 B        
-------------------------------------------
ISIN code:   SE0020539XXX        
-------------------------------------------
Orderbook ID:  299806           
-------------------------------------------





Terms: Each warrant of series TO3 B entitles the holder to subscribe for one  
     (1) new share in the company. Subscription will be at a subscription  
     price equal to 70 percent of the volume weighted average price paid for
     the company's shares on the Nasdaq First North Growth Market from   
     January 25, 2024, to February 7, 2024. The subscription price cannot be
     less than the quota value of the shares or higher than 0.53 SEK.    
--------------------------------------------------------------------------------
   -                                     
--------------------------------------------------------------------------------
Subscr February 9, 2024 - February 23, 2024.                  
iption                                     
 perio                                     
d:                                       
--------------------------------------------------------------------------------
Last  February 20, 2024.                           
 tradi                                     
ng                                       
 day:                                      
--------------------------------------------------------------------------------



This information is distributed at the request of the Certified Adviser,
Mangold Fondkommission AB. For further information, please call Mangold
Fondkommission AB on [phone].